WASHINGTON D.C. – The U.S. Food and Drug Administration (FDA) has officially cleared the Aktiia Hilo, a revolutionary cuffless blood pressure monitor, heralding a new era of unobtrusive health tracking and, according to some, the end of blissful ignorance. The device, worn like a wristwatch, promises continuous, highly accurate readings without the cumbersome squeeze of traditional cuffs, allowing users to track their cardiovascular health with terrifying precision.

“This is a monumental leap forward for personal health data,” stated Dr. Philomena Girth, Director of the FDA’s Department of Perpetual Physiological Oversight, in a press release issued Tuesday at 3:17 PM EST. “No longer will individuals be able to enjoy a second slice of pizza or a particularly stressful email without immediate, incontrovertible evidence of their body’s betrayal.”

Critics, however, express concern that the device’s discretion could lead to an epidemic of hyper-vigilance. “What happens when every single spike, every tiny fluctuation, is instantly available?” pondered Professor Quentin Quibble, Head of Existential Cardiology at the Institute for Advanced Hypochondria. “We’re creating a generation of people who will monitor their blood pressure while monitoring their blood pressure. It’s a feedback loop of anxiety.”

Early adopters report a newfound inability to relax. “I used to just feel a little stressed, now I have a graph to prove it,” confessed Brenda Pumble, 47, a self-described 'wellness enthusiast' from Topeka. “My device tells me my systolic pressure jumped 8 points during the last episode of 'The Great British Bake Off.' It’s ruined cake for me.” The FDA maintains the benefits of early detection outweigh the potential for widespread neuroticism.